We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Heart Procedure Uses Bipolar RF Energy

By HospiMedica staff writers
Posted on 23 Oct 2001
An animal study has shown that a new technique to correct atrial fibrillation using biopolar radiofrequency (RF) power requires less time than the traditional treatment, produces lower temperatures, but still permanently alters electrical connections in the heart that cause atrial fibrillation. More...
The study was presented at the 2001 Clinical Congress of the American College of Surgeons in New Orleans (LA, USA) by Dr. Sunil M. Prasad, a surgical fellow at Washington University School of Medicine (St. Louis, Mo. USA) and the lead author.

The traditional treatment, called the Maze procedure, is technically difficult, time-consuming, and keeps patients on the heart-lung machine for several hours. Surgeons at Washington University will be using the new RF technique in conjunction with the Maze procedure on patients undergoing coronary artery bypass grafting who cannot tolerate additional time on the heart-lung machine and on patients whose atrial fibrillation cannot be controlled with medications.

They are using bipolar RF because it offers advantages over unipolar RF. In the animal study, the procedure generated temperatures of only 40-50 degrees C 1 mm from the probe and took only nine seconds to create transmural lesions that persisted for up to 30 days. The technique successfully achieved both acute and chronic isolation of the tissue from surrounding electrical activities, which showed that transmural ablation had occurred. The average length of hospital stay for patients who have the Maze procedure is seven to 10 days. Patients having the new technique would theoretically need be in the hospital for only a day or two.

"This study indicates to us that the procedure is effective and safe to do in patients.” Said Dr. Ralph J. Damiamo, professor of surgery at Washington University. "We are refining the technique so it can be done on the beating heart without placing patients on the heart-lung machine, which should minimize complications and accelerate recovery.”




Related Links:
Washington University School of Medicine

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.